The ongoing investigations of CVS Caremark and the so-called “pay-for-delay” agreements between brand name and generic drug manufacturers appear to be high priorities for the U.S. Federal Trade Commission, based on Chairman Jon Leibowitz’s recent testimony on Capitol Hill.
Archive for May, 2010
Tags: CVS Caremark
Community pharmacists held over 200 meetings with Members of Congress and their staffs in Washington this month and, during the Memorial Day recess next week, pharmacists are playing the hosts and opening their doors to lawmakers.
Tags: pharmacy benefit managers
By Devin Stone
The lobby for pharmacy benefit managers (PBMs) produced a “study” recently that once again fails to pass the smell test. The study, authored by the Moran Company, follows a long line of literature funded by the Pharmaceutical Care Management Association (PCMA) that is at odds with objective, non-partisan studies commissioned by the Congressional Budget Office (CBO). To review,
Tags: Health Care Reform, pharmacy benefit managers
Some of Congress’ staunchest community pharmacy champions rallied in front of the U.S. Capitol as pharmacists prepared to set out for a day of 200+ meetings with U.S. Senators and Representatives – a fitting conclusion to NCPA’s three-day Legislation and Government Affairs Conference.
Tags: drug disposal, durable medical equipment, Health Care Reform, Medicaid
Top Democrats and Republicans in Congress and other senior federal officials shared their views on issues affecting pharmacy, during the second day of NCPA’s 2010 National Legislation and Government Affairs Conference.
Tags: CVS Caremark
Many of Washington’s biggest players in health care addressed NCPA’s 42nd Annual Legislation and Government Affairs Conference last week. Here’s a re-cap of some of the opening day’s noteworthy speakers:
Community pharmacists and state Medicaid directors are watching a pair of state plan amendments Alabama is expected to propose soon to the U.S. Centers for Medicare and Medicaid Services.